NORDSON CORP, 10-Q filed on 2/19/2026
Quarterly Report
v3.25.4
Cover Page - shares
 3 Months Ended
Jan. 31, 2026
Feb. 18, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jan. 31, 2026  
Document Transition Report false  
Entity File Number 0-7977  
Entity Registrant Name NORDSON CORPORATION  
Entity Incorporation, State or Country Code OH  
Entity Tax Identification Number 34-0590250  
Entity Address, Address Line One 28601 Clemens Road  
Entity Address, City or Town Westlake  
Entity Address, State or Province OH  
Entity Address, Postal Zip Code 44145  
City Area Code 440  
Local Phone Number 892-1580  
Title of 12(b) Security Common Shares, without par value  
Trading Symbol NDSN  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   55,783,598
Amendment Flag false  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Entity Central Index Key 0000072331  
Current Fiscal Year End Date --10-31  
v3.25.4
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Income Statement [Abstract]    
Sales $ 669,461 $ 615,420
Costs and Expenses [Abstract]    
Cost of sales 303,339 279,524
Selling and administrative expenses 199,717 194,949
Operating profit 166,405 140,947
Nonoperating Income (Expense) [Abstract]    
Interest expense (23,131) (26,559)
Interest and investment income 390 941
Other - net 20,837 1,526
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total 164,501 116,855
Income tax expense 31,119 22,203
Net income $ 133,382 $ 94,652
Average common shares (in shares) 55,789 57,129
Incremental common shares attributable to equity compensation (in shares) 338 357
Average common shares attributable and common share equivalents (in shares) 56,127 57,486
Basic earnings per share (in dollars per share) $ 2.39 $ 1.66
Diluted earnings per share (in dollars per share) $ 2.38 $ 1.65
v3.25.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Statement of Comprehensive Income [Abstract]    
Net income $ 133,382 $ 94,652
Components of other comprehensive income (loss), net of tax:    
Foreign currency translation and related hedging adjustments 42,959 (51,679)
Pension and postretirement benefit plans 295 512
Total other comprehensive income 43,254 (51,167)
Total comprehensive income $ 176,636 $ 43,485
v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Current assets:    
Cash and cash equivalents $ 120,392 $ 108,442
Receivables - net 571,583 587,843
Inventories - net 451,138 444,814
Prepaid expenses and other current assets 108,558 101,752
Total current assets 1,251,671 1,242,851
Goodwill 3,332,244 3,304,685
Intangible assets - net 671,456 681,587
Property, plant and equipment - net 521,508 516,914
Operating right of use lease assets 69,758 77,478
Deferred income taxes 11,320 11,246
Other assets 102,965 82,920
Assets, Total 5,960,922 5,917,681
Current liabilities:    
Current maturities of long-term debt and notes payable 54,312 315,000
Accrued liabilities 182,964 229,095
Accounts payable 117,708 121,006
Customer advanced payments 47,783 44,009
Income taxes payable 35,060 25,856
Operating lease liability - current 16,238 17,402
Finance lease liability - current 5,984 5,892
Total current liabilities 460,049 758,260
Long-term debt 1,943,182 1,681,254
Operating lease liability - noncurrent 56,747 64,451
Deferred income taxes 194,321 192,186
Postretirement obligations 43,548 43,786
Pension obligations 44,903 43,205
Finance lease liability - noncurrent 8,210 8,359
Other long-term liabilities 97,856 82,609
Shareholders' equity:    
Common shares 12,253 12,253
Capital in excess of stated value 762,137 740,789
Retained earnings 4,688,200 4,600,604
Accumulated other comprehensive loss (57,203) (100,457)
Common shares in treasury, at cost (2,293,281) (2,209,618)
Total shareholders' equity 3,112,106 3,043,571
Total shareholders' equity $ 5,960,922 $ 5,917,681
v3.25.4
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Common Shares in Treasury, at cost
Beginning balance at Oct. 31, 2024 $ 2,932,192 $ 12,253 $ 714,091 $ 4,295,199 $ (184,840) $ (1,904,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued under company stock and employee benefit plans 1,001   349     652
Stock-based compensation 4,633   4,633      
Purchase of treasury shares (60,098)         (60,098)
Dividends declared (44,602)     (44,602)    
Net income 94,652     94,652    
Ending balance at Jan. 31, 2025 2,876,611 12,253 719,073 4,345,249 (236,007) (1,963,957)
Components of other comprehensive income (loss), net of tax:            
Other Comprehensive Income (Loss), Net of Tax (51,167)       (51,167)  
Beginning balance at Oct. 31, 2025 3,043,571 12,253 740,789 4,600,604 (100,457) (2,209,618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued under company stock and employee benefit plans 18,795   16,457     2,338
Stock-based compensation 4,891   4,891      
Purchase of treasury shares (86,001)         (86,001)
Dividends declared (45,786)     (45,786)    
Net income 133,382     133,382    
Ending balance at Jan. 31, 2026 3,112,106 $ 12,253 $ 762,137 $ 4,688,200 (57,203) $ (2,293,281)
Components of other comprehensive income (loss), net of tax:            
Other Comprehensive Income (Loss), Net of Tax $ 43,254       $ 43,254  
v3.25.4
Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Statement of Stockholders' Equity [Abstract]    
Dividends declared (in dollars per share) $ 0.82 $ 0.78
v3.25.4
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Cash flows from operating activities:    
Net income $ 133,382 $ 94,652
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of intangibles 36,585 37,031
Non-cash stock compensation 4,891 4,633
Deferred income taxes 5,620 (2,223)
Other non-cash (income) expense (21,410) 584
(Gain) loss on sale of property, plant and equipment (776) 166
Changes in operating assets and liabilities and other (17,864) 24,279
Net cash provided by operating activities 140,428 159,122
Cash flows from investing activities:    
Additions to property, plant and equipment (17,513) (21,399)
Proceeds from sale of property, plant and equipment 1,103 298
Other (1,261) 6,825
Net cash used in investing activities (17,671) (14,276)
Cash flows from financing activities:    
Proceeds from issuance of debt 267,360 1,655
Repayment of debt (264,993) (24,218)
Repayment of finance lease obligations (1,616) (1,320)
Issuance of common shares 18,795 1,001
Purchase of treasury shares (86,001) (60,098)
Dividends paid (45,786) (44,602)
Net cash used in financing activities (112,241) (127,582)
Effect of exchange rate changes on cash 1,434 (2,792)
Increase in cash and cash equivalents 11,950 14,472
Cash and cash equivalents at beginning of period 108,442 115,952
Cash and cash equivalents at end of period $ 120,392 $ 130,424
v3.25.4
Significant accounting policies
 3 Months Ended
Jan. 31, 2026
Accounting Policies [Abstract]  
Significant accounting policies
Significant accounting policies
Basis of presentation.  The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States ("U.S. GAAP") for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended January 31, 2026 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes included in our Annual Report on Form 10-K for the year ended October 31, 2025.
Consolidation.  The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.  
Use of estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements. Actual amounts could differ from these estimates.
Revenue recognition. A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. For products in which control transfers upon delivery, revenue is deferred for undelivered items and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of January 31, 2026 and October 31, 2025 were not material.
For certain contracts related to the sale of customer-specific products, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled, and we are contractually entitled to payment for work performed to date plus a reasonable margin.  
As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material as of January 31, 2026 and October 31, 2025. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues for the periods ended January 31, 2026 and October 31, 2025.
Revenue is measured as the amount of consideration we expect to be entitled to in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs, as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred, as the amortization period resulting from capitalizing the
costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income.
We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and is not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and therefore, these items are typically regarded as inconsequential or not material.
We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details.
Earnings per share.  Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options for 73 and 193 common shares were excluded from the calculation of diluted earnings per share for the three months ended January 31, 2026 and 2025, respectively, because their effect would have been anti-dilutive. Under the 2021 Stock Incentive and Award Plan, executive officers and selected other key employees receive common share awards based on corporate performance measures over three-year performance periods. Awards for which performance measures have not been met were excluded from the calculation of diluted earnings per share.
v3.25.4
Recently issued accounting standards
 3 Months Ended
Jan. 31, 2026
Accounting Changes and Error Corrections [Abstract]  
Recently issued accounting standards
Recently issued accounting standards
v3.25.4
Acquisitions
 3 Months Ended
Jan. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisitions
Acquisitions
Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Condensed Consolidated Statements of Income.
v3.25.4
Receivables
 3 Months Ended
Jan. 31, 2026
Credit Loss [Abstract]  
Receivables
Receivables
Our primary allowance for credit losses is the allowance for doubtful accounts, which is principally determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the review of customer information, credit ratings, approval and monitoring of customer credit limits and assessment of market conditions. We may also require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term
in nature with a majority of receivables outstanding less than 90 days. Accounts receivable balances are written-off against the allowance if deemed uncollectible.
Accounts receivable are net of an allowance for credit losses of $6,504 and $7,408 on January 31, 2026 and October 31, 2025, respectively. Provision income was $589 for the three months ended January 31, 2026 compared to provision income of $382 for the three months ended January 31, 2025. The remaining change in the allowance for credit losses is principally related to the write-off of uncollectible accounts.
v3.25.4
Inventories
 3 Months Ended
Jan. 31, 2026
Inventory Disclosure [Abstract]  
Inventories
Inventories
Components of inventories were as follows:
 January 31, 2026October 31, 2025
Finished goods$243,587 $234,710 
Raw materials and component parts227,554 230,907 
Work-in-process61,504 57,306 
 532,645 522,923 
Obsolescence and other reserves(81,507)(78,109)
 $451,138 $444,814 
v3.25.4
Property, Plant and Equipment
 3 Months Ended
Jan. 31, 2026
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
Property, Plant and Equipment
Components of property, plant and equipment were as follows:
January 31, 2026October 31, 2025
Land$32,761 $32,579 
Land improvements4,939 4,914 
Buildings363,125 360,038 
Machinery and equipment690,721 682,093 
Enterprise management system53,694 53,694 
Construction-in-progress40,298 29,522 
Leased property under finance leases28,656 27,680 
 1,214,194 1,190,520 
Accumulated depreciation(692,686)(673,606)
 $521,508 $516,914 
Depreciation expense was $17,016 and $17,720 for the three months ended January 31, 2026 and 2025, respectively.
v3.25.4
Goodwill and other intangible assets
 3 Months Ended
Jan. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and other intangible assets
Goodwill and other intangible assets  
Our reporting units are the same as our reportable operating segments, Industrial Precision Solutions ("IPS"), Medical and Fluid Solutions ("MFS"), and the Advanced Technology Solutions ("ATS") segments. Changes in the carrying amount of goodwill for the three months ended January 31, 2026 by operating segment:
 IPSMFSATSTotal
Balance at October 31, 2025$1,210,366 $1,647,468 $446,851 $3,304,685 
Currency effect23,125 1,163 3,271 27,559 
Balance at January 31, 2026$1,233,491 $1,648,631 $450,122 $3,332,244 
Information regarding intangible assets subject to amortization:
 January 31, 2026
 Carrying 
Amount		Accumulated
Amortization		Net Book 
Value
Customer relationships$910,541 $405,243 $505,298 
Patent/technology costs237,558 162,588 74,970 
Trade name170,403 79,215 91,188 
Non-compete agreements8,686 8,686 — 
Other921 921 — 
Total$1,328,109 $656,653 $671,456 
 October 31, 2025
 Carrying 
Amount		Accumulated
Amortization		Net Book 
Value
Customer relationships$899,402 $390,751 $508,651 
Patent/technology costs235,255 155,865 79,390 
Trade name169,127 75,581 93,546 
Non-compete agreements8,596 8,596 — 
Other929 929 — 
Total$1,313,309 $631,722 $681,587 
Amortization expense for the three months ended January 31, 2026 and 2025 was $19,569 and $19,311, respectively.
v3.25.4
Pension and other postretirement plans
 3 Months Ended
Jan. 31, 2026
Retirement Benefits [Abstract]  
Pension and other postretirement plans
Pension and other postretirement plans
The components of net periodic pension costs for the three months ended January 31, 2026 and 2025 were:
 U.S.International
2026202520262025
Service cost$2,062 $2,531 $133 $232 
Interest cost4,580 4,691 604 623 
Expected return on plan assets(6,645)(6,609)(547)(638)
Amortization of prior service credit— — (2)(2)
Amortization of net actuarial (gain) loss1,051 474 (86)(67)
Total benefit cost$1,048 $1,087 $102 $148 
The components of other postretirement benefit costs, for plans in the United States, for the three months ended January 31, 2026 and 2025:
20262025
Service cost$35 $59 
Interest cost522 650 
Amortization of net actuarial gain(413)(126)
Total benefit cost$144 $583 
The components of net periodic pension and other postretirement cost, other than service cost, are included in Other – net in our Condensed Consolidated Statements of Income.
v3.25.4
Income taxes
 3 Months Ended
Jan. 31, 2026
Income Tax Disclosure [Abstract]  
Income taxes
Income taxes
We record our interim provision for income taxes based on our estimated annual effective tax rate, as well as certain items discrete to the current period. The effective tax rate for the three months ended January 31, 2026 and 2025 was 18.9% and 19.0%, respectively. The effective tax rate for the three months ended January 31, 2026 was lower than the U.S. tax rate of 21% primarily due to the foreign-derived intangible income deduction.
One Big Beautiful Bill Act
On July 4, 2025, the One Big Beautiful Bill Act (the "OBBBA") was signed into law in the United States. The OBBBA includes significant tax law changes, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. While several provisions under the OBBBA begin to take effect during the Company’s fiscal year ended October 31, 2026, the OBBBA did not have a material impact on the Company’s consolidated financial statements in the three months ended January 31, 2026. The Company will continue to assess the impact of the OBBBA for the year ending October 31, 2026. The OBBBA is not expected to have a material impact on the effective tax rate.
v3.25.4
Accumulated other comprehensive loss
 3 Months Ended
Jan. 31, 2026
Equity [Abstract]  
Accumulated other comprehensive loss
Accumulated other comprehensive income (loss)
Changes in accumulated other comprehensive income (AOCI) consisted of:
Cumulative
translation and related hedging instruments		Pension and
postretirement 
benefit plan
adjustments		Accumulated
other 
comprehensive
income (loss)
Balance at October 31, 2025 (1)
$(50,518)$(49,939)$(100,457)
Other comprehensive income before reclassification adjustments36,775 (131)36,644 
Reclassifications from AOCI to Statement of Income (2)
— 550 550 
Tax impact6,184 (124)6,060 
Balance at January 31, 2026 (1)
$(7,559)$(49,644)$(57,203)
(1) Amounts net of tax.
(2) Included in the computation of net periodic cost (benefit) which is included in Other - net in our Consolidated Statements of Income. See Pension and other postretirement plans Note.
v3.25.4
Warranties
 3 Months Ended
Jan. 31, 2026
Guarantees [Abstract]  
Warranties
Warranties
We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) measured from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheets.
Following is a reconciliation of the product warranty liability for the three months ended January 31, 2026 and 2025:
 20262025
Beginning balance at October 31$13,900 $13,538 
Accruals for warranties3,022 1,596 
Warranty payments(2,854)(2,856)
Currency adjustments233 (351)
Ending balance$14,301 $11,927 
v3.25.4
Operating segments
 3 Months Ended
Jan. 31, 2026
Segment Reporting [Abstract]  
Operating segments
Operating segments
We conduct business in three primary operating segments: 
Industrial Precision Solutions: This segment focuses on delivering proprietary dispensing and processing technology, both standard and highly customized equipment, to diverse end markets. Product lines commonly reduce material consumption, increase line efficiency through precision dispensing and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, agricultural, consumer durables and non-durables markets.
Medical and Fluid Solutions: This segment includes the Company’s fluid management solutions for medical, high-tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips and fluid connection components are used to dispense or control fluids within customers’ medical devices or products, as well as production processes.
Advanced Technology Solutions: This segment focuses on products serving electronics and consumer non-durable end markets. Advanced Technology Solutions products integrate our proprietary product technologies found in progressive stages of an electronics customer’s production and measurement and control processes, such as surface treatment, precisely controlled dispensing of material and test and inspection to ensure quality and reliability. Applications include, but are not limited to, semiconductors, printed circuit boards, electronic components and automotive electronics, in-line measurement sensors, gauges and analyzers.
The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker ("CODM"), our President and Chief Executive Officer. The primary measure used by our CODM for purposes of making decisions about allocating resources to the segments and assessing performance is segment EBITDA, which equals sales less adjusted cost of sales and adjusted selling and administrative expenses plus depreciation. Cost of sales and selling and administrative expenses are adjusted for certain special items such as non-recurring cost reduction activities and acquisition related costs, including intangible asset amortization. The CODM uses segment EBITDA in the annual budgeting and forecasting processes and regularly evaluates segment EBITDA results versus budget, forecast and prior year when making allocation of capital, financial and employee resource decisions.
The accounting policies of the segments are the same as those described in our Significant accounting policies Note. There are no intersegment sales. Certain expenses are maintained at the corporate level and not allocated to the segments. These expenses include executive compensation, charitable donations, corporate facilities, and other items that are of a corporate or functional governance nature. Interest expense-net and other income/expense-net are excluded from the measure of segment profitability reviewed by our CODM and are not presented by operating segment.
The following table presents information about our reportable segments as further reconciled to consolidated GAAP financial results:
Three Months Ended
January 31, 2026January 31, 2025
Sales
Industrial Precision Solutions$326,861 $300,448 
Medical and Fluid Solutions193,183 193,609 
Advanced Technology Solutions149,417 121,363 
Total segment sales669,461 615,420 
Adjusted cost of sales
Industrial Precision Solutions(134,755)(113,147)
Medical and Fluid Solutions(96,555)(103,369)
Advanced Technology Solutions(72,029)(54,859)
Total segment adjusted cost of sales(303,339)(271,375)
Adjusted selling and administrative expenses
Industrial Precision Solutions(87,750)(80,169)
Medical and Fluid Solutions(34,261)(34,612)
Advanced Technology Solutions(46,375)(45,317)
Total segment adjusted selling and administrative expenses(168,386)(160,098)
Depreciation
Industrial Precision Solutions5,955 5,644 
Medical and Fluid Solutions7,840 8,704 
Advanced Technology Solutions1,587 1,584 
Total segment depreciation15,382 15,932 
EBITDA
Industrial Precision Solutions110,311 112,776 
Medical and Fluid Solutions70,206 64,332 
Advanced Technology Solutions32,600 22,771 
Total segment EBITDA213,117 199,879 
Inventory step-up amortization— (3,135)
Acquisition related costs— (1,030)
Severance and other— (5,961)
Depreciation and amortization(36,585)(37,030)
Corporate expenses(10,127)(11,776)
Interest expense(23,131)(26,559)
Interest and investment income390 941 
Other - net20,837 1,526 
Income before taxes$164,501 $116,855 
The following table presents additional information about our reportable segments for the three months ended or period ended:
Industrial Precision SolutionsMedical and Fluid SolutionsAdvanced Technology SolutionsCorporateTotal
January 31, 2026
Amortization of intangibles$7,520 $9,671 $2,378 $— $19,569 
Identifiable assets (1)
1,881,578 2,187,997 747,941 1,143,406  5,960,922 
Property, plant and equipment expenditures3,265 5,325 8,717 206 17,513 
January 31, 2025
Amortization of intangibles$6,810 $9,437 $3,064 $— $19,311 
Identifiable assets (1)
1,737,555 2,240,225 734,046 1,159,700 5,871,526 
Property, plant and equipment expenditures5,070 9,330 2,124 4,875 21,399 
(1) Operating segment identifiable assets include notes and accounts receivable net of allowance for doubtful accounts, inventories net of reserves, property, plant and equipment net of accumulated depreciation and goodwill. Corporate assets are principally cash and cash equivalents, deferred income taxes, leases, headquarter facilities and intangible assets.
We had significant net sales, measured based on their geographic destination, and long-lived assets in the following geographic areas:
January 31, 2026January 31, 2025
Net external sales for three months ended
Americas$261,930 $267,836 
Europe182,461 167,762 
Asia Pacific225,070 179,822 
Total net external sales$669,461 $615,420 
Long-lived assets
Americas$421,462 $465,600 
Europe108,566 103,813 
Asia Pacific61,238 56,849 
Total long-lived assets$591,266 $626,262 
Net external sales in the United States were $198,523 for the three months ended January 31, 2026 and $208,820 for the three months ended January 31, 2025. Long-lived assets include property, plant and equipment - net and operating right of use lease assets. Long-lived assets in the U.S. were $412,713 and $450,029 as of January 31, 2026 and 2025, respectively.
v3.25.4
Investments, All Other Investments
 3 Months Ended
Jan. 31, 2026
Investments, All Other Investments [Abstract]  
Investment
Investments
The Company holds minority interests in certain companies that do not have readily determinable fair values. For each qualifying investment, the Company elects the measurement alternative under ASC 321, initially recognizing the investment at cost and subsequently adjusting the carrying amount for (i) impairment, and (ii) observable price changes in orderly transactions for an identical or similar investment of the same issuer. Investments subject to the measurement alternative are classified in Other assets on the Consolidated Balance Sheets and were $7,335 and $13,996, at January 31, 2026 and October 31, 2025, respectively. Adjustments (upward or downward) and impairment losses, if any, are recognized in earnings within Other-net and were not material for fiscal 2026 and 2025. If a readily determinable fair value for the investments subsequently becomes available, we will be required to record the investment at fair value with any unrealized gains or losses being recognized in earnings each period.
In December 2025, one of the Company's minority interest investments was publicly listed on a foreign stock exchange. The fair value of this investment is included in Other assets on the Consolidated Balance Sheets and was $29,238 as of January 31, 2026. The unrealized gain of $22,238 for the three months ended January 31, 2026 was included in Other-net in the Condensed Consolidated Statements of Income. Nordson is contractually restricted from selling any shares in this investment until December 2028 and there are no circumstances that could cause this restriction to lapse earlier.
v3.25.4
Fair value measurements
 3 Months Ended
Jan. 31, 2026
Fair Value Disclosures [Abstract]  
Fair value measurements
Fair value measurements
The inputs to the valuation techniques used to measure fair value are classified into the following categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data.
The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis:
January 31, 2026TotalLevel 1Level 2Level 3
Net derivative contracts (1)
$(59,465)$— $(59,465)$— 
Deferred compensation plans (2)
(13,356)— (13,356)— 
Minority interest investment (3)
29,238 29,238 — — 
October 31, 2025TotalLevel 1Level 2Level 3
Net derivative contracts (1)
$(55,367)$— $(55,367)$— 
Deferred compensation plans (2)
(11,885)— (11,885)— 
(1) Derivative contracts are valued using an industry standard market approach, in which prices and other relevant information is generated by market transactions involving identical or comparable assets or liabilities. Refer to Derivative financial instruments note for balance sheet classification of derivatives.
(2) Executive officers and other highly compensated employees may defer up to 100% of their salary and annual cash incentive compensation and for executive officers, up to 90% of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.
(3) Refer to Investments note for additional details.
The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables and accounts payable are shown in the table below. The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments.
 January 31, 2026October 31, 2025
 Carrying AmountFair ValueCarrying AmountFair Value
Long-term debt (including current portion)$1,984,051 $2,041,426 $1,996,254 $2,038,869 
Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy. The carrying amount of long-term debt is shown net of unamortized debt issuance costs and bond discounts as described in the Long-term debt Note.
v3.25.4
Derivative financial instruments
 3 Months Ended
Jan. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative financial instruments
Derivative financial instruments  
The Company uses derivative instruments to manage foreign currency and interest rate risk as detailed below. The Company does not enter into derivative instruments for trading purposes.
Foreign Currency Forward Contracts
We operate internationally and enter into transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. The settlement of these contracts is recorded in operating activities on the Consolidated Statement of Cash Flows.
We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. As of January 31, 2026 and 2025, there were no significant concentrations of credit risk.
Net Investment Hedges
Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We may utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries.
The Company is a party to various cross currency swaps between the U.S. dollar and Euro, Japanese Yen, Taiwan dollar, Singapore dollar and Chinese Yuan, which were designated as hedges of our net investments in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. Any increases or decreases related to the remeasurement of the effective portion of the hedges are recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance Sheets until the sale or substantial liquidation of the underlying investments. The settlement of these hedges is recorded in investing activities on the Consolidated Statement of Cash Flows. The interest component is recorded in operating activities on the Consolidated Statement of Cash Flows.
Fair Value Hedges of Interest Rate Risk
The Company is exposed to changes in the fair value of certain of its fixed-rate liabilities due to changes in benchmark interest rates. The Company uses interest rate swaps to manage its exposure to changes in fair value on these instruments attributable to changes in the designated benchmark interest rate, the Secured Overnight Financing Rate ("SOFR"), with the objective of minimizing the cost of borrowed funds. The Company's interest rate swaps involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments without the exchange of the underlying notional amount.
The Company's interest rate swaps are designated and qualify as fair value hedges. As a result, the interest rate swaps are measured at fair value and the carrying value of the hedged debt is adjusted for the change in value related to the exposure being hedged, with both adjustments offset to earnings. Accordingly, the earnings effect of an increase in the fair value of the interest rate swaps will be substantially offset by the earnings effect of the increase in the carrying value of the hedged debt.
The following table provides information regarding the Company's outstanding interest rate derivatives that were used to hedge changes in fair value attributable to interest rate risk:
Interest rate swaps - notional amountCumulative adjustment to long-term debt from application of hedge accountingCarrying value of hedged debt
Interest rate swaps$300,000 $9,131 $309,131 
The following table provides information regarding the balance sheet and income statement impacts of the Company's derivatives:
January 31, 2026Notional Amount $Prepaid and other current assetsOther assetsAccrued liabilitiesOther long-term liabilitiesType of hedge
Derivatives designated as hedges:
Cross-currency swap$928,098 $3,839 $— $10,041 $75,583 Net investment
Interest rate swap300,000 1,396 7,735 — — Fair value
Derivatives not designated as hedges:
Foreign currency forward contracts1,036,125 14,704 — 1,515 — 
Total$19,939 $7,735 $11,556 $75,583 
October 31, 2025Notional Amount $Prepaid and other current assetsOther assetsAccrued liabilitiesOther long-term liabilitiesType of hedge
Derivatives designated as hedges:
Cross-currency swap$863,904 $5,937 $73 $— $10,675 $676 $61,725 Net investment
Interest rate swap300,000 1,133 10,353 — — Fair value
Derivatives not designated as hedges:
Foreign currency forward contracts1,137,956 4,961 — 15,350 — 
Total$12,031 $10,353 $16,026 $61,725 
 Gain (Loss) Recognized Location
January 31, 2026January 31, 2025
Derivatives designated as hedges:
   Interest rate swaps$(2,355)$2,986  Interest expense
   Hedged item$2,355 $(2,986) Interest expense
   Cross-currency swap - interest component$3,628 $3,737  Interest expense
   Cross-currency swap - effective portion$(26,560)$37,038  Cumulative translation
Derivatives not designated as hedges
   Foreign currency forward contracts$23,579 $(4,363) Other-net
Foreign currency balance sheet remeasurement$(25,873)$4,694  Other-net
v3.25.4
Long-term debt
 3 Months Ended
Jan. 31, 2026
Debt Disclosure [Abstract]  
Long-term debt
Long-term debt
A summary of long-term debt is as follows:
 January 31, 2026October 31, 2025
Notes Payable $4,312 $— 
Revolving credit agreement, due 2031400,000 — 
Revolving credit agreement, due 2028— 135,000 
Term loan due 2026— 265,000 
Senior notes, due 2026-202720,000 20,000 
Senior notes, due 2026-2030130,000 130,000 
5.600% Notes due 2028350,000 350,000 
5.800% Notes due 2033500,000 500,000 
4.500% Notes due 2029600,000 600,000 
 2,004,312 2,000,000 
Less current maturities54,312 315,000 
Less unamortized debt issuance costs13,978 13,167 
Less bond discounts1,971 2,065 
Plus impact of interest rate swaps9,131 11,486 
Long-term maturities$1,943,182 $1,681,254 
Revolving credit agreement — In January 2026, we entered into a $1,200,000 senior unsecured multicurrency revolving credit facility with a group of banks, maturing in January 2031 (the “Revolving Credit Agreement”), which amended and restated the Company’s previous unsecured senior credit agreement, dated June 6, 2023, that included a term loan facility in the aggregate principal amount of $300,000, maturing in June 2026, and a multicurrency revolving credit facility in the aggregate principal amount of $922,500, maturing in June 2028. The Company borrowed and had $400,000 outstanding on the Revolving Credit Agreement as of January 31, 2026. The Revolving Credit Agreement permits borrowing in U.S. Dollars, Euros, Sterling, Swiss Francs, Singapore Dollars, Japanese Yen, and each other currency approved by the Revolving Agent and the Revolving Credit Banks (each as defined in the Revolving Credit Agreement). Loans under the Revolving Credit Agreement bear interest at the sum of (i) either a base rate or, depending on the currency, a SOFR rate, EURIBOR rate, TIBOR rate, SORA rate, SONIA rate or SARON rate (each as defined in the Revolving Credit Agreement) plus (ii) an applicable margin. The applicable margin is based on either the Company’s Leverage Ratio (as defined in the Revolving Credit Agreement) or then current Debt Rating (as defined in the Revolving Credit Agreement). The weighted-average interest rate at January 31, 2026 was 4.69%.
Senior notes, due 2026-2027 — These unsecured fixed-rate notes entered into in 2015 with a group of insurance companies have a remaining weighted-average life of 0.99 years. The weighted-average interest rate at January 31, 2026 was 3.19%.
Senior notes, due 2026-2030 — These unsecured fixed-rate notes entered into in 2018 with a group of insurance companies have a remaining weighted-average life of 2.39 years. The weighted-average interest rate at January 31, 2026 was 4.08%.  
5.600% Notes due 2028 and 5.800% Notes due 2033 — In September 2023, we completed an underwritten public offering of $350,000 aggregate principal amount of 5.600% Notes due 2028 and $500,000 aggregate principal amount of 5.800% Notes due 2033.
4.500% Notes due 2029 — In September 2024, we completed an underwritten public offering of $600,000 aggregate principal amount of 4.500% Notes due 2029.
We were in compliance with all covenants at January 31, 2026, and the amount we could borrow would not have been limited by any debt covenants.
v3.25.4
Contingencies
 3 Months Ended
Jan. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Contingencies
Contingencies
We are involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee and other matters arising from the normal course of business. After consultation with legal counsel, we do not believe that losses in excess of the amounts we have accrued would have a material adverse effect on our financial condition, quarterly or annual operating results or cash flows.
v3.25.4
Insider Trading Arrangements
 3 Months Ended
Jan. 31, 2026
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Trading Arrangement
ActionAction Date
Rule 10b5-11
Non-Rule 10b5-12
Total Shares to be SoldExpiration Date
Sundaram Nagarajan
Chief Executive Officer
Terminated3
1/12/2026x
Up to 41,8004 shares
7/10/2026
Sundaram Nagarajan
Chief Executive Officer
Adopted1/12/2026x
Up to 41,8005 shares
12/31/2026
Joseph P. Kelley
Executive Vice President
Adopted1/16/2026x
Up to 2,310 shares
1/15/2027
1 Intended to satisfy the affirmative defense of Rule 10b5-1(c)
2 Not intended to satisfy the affirmative defense of Rule 10b5-1(c)
3 The 10b5-1 Plan originally adopted by Mr. Nagarajan on April 3, 2025, was terminated in connection with the adoption of a new Rule 10b5-1 Plan on January 12, 2026.
4 The Company’s prior disclosure in its Quarterly Report on Form 10‑Q for the quarterly period ended April 30, 2025 incorrectly stated that terminated Rule 10b5-1 Plan covered 40,000 shares. The correct number of shares covered under the terminated Rule 10b5-1 Plan was 41,800 shares.
5 Mr. Nagarajan's Rule 10b5-1 Plan provides for the potential sale of up to 41,800 shares of the Company’s common stock, all of which Mr. Nagarajan may acquire upon the exercise of outstanding stock options.
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Sundaram Nagarajan [Member]  
Trading Arrangements, by Individual  
Name Sundaram Nagarajan
Title Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date 1/12/2026
Rule 10b5-1 Arrangement Terminated true
Termination Date 1/12/2026
Aggregate Available 41,800
Joseph P. Kelley [Member]  
Trading Arrangements, by Individual  
Name Joseph P. Kelley
Title Executive Vice President
Rule 10b5-1 Arrangement Adopted true
Adoption Date 1/16/2026
Aggregate Available 2,310
v3.25.4
Significant accounting policies (Policies)
 3 Months Ended
Jan. 31, 2026
Accounting Policies [Abstract]  
Basis of presentation Basis of presentation.  The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States ("U.S. GAAP") for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended January 31, 2026 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes included in our Annual Report on Form 10-K for the year ended October 31, 2025.
Consolidation Consolidation.  The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of estimates
Use of estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements. Actual amounts could differ from these estimates.
Revenue recognition
Revenue recognition. A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. For products in which control transfers upon delivery, revenue is deferred for undelivered items and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of January 31, 2026 and October 31, 2025 were not material.
For certain contracts related to the sale of customer-specific products, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled, and we are contractually entitled to payment for work performed to date plus a reasonable margin.  
As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material as of January 31, 2026 and October 31, 2025. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues for the periods ended January 31, 2026 and October 31, 2025.
Revenue is measured as the amount of consideration we expect to be entitled to in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs, as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred, as the amortization period resulting from capitalizing the
costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income.
We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and is not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and therefore, these items are typically regarded as inconsequential or not material.
We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details.
Earnings per share
Earnings per share.  Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options for 73 and 193 common shares were excluded from the calculation of diluted earnings per share for the three months ended January 31, 2026 and 2025, respectively, because their effect would have been anti-dilutive. Under the 2021 Stock Incentive and Award Plan, executive officers and selected other key employees receive common share awards based on corporate performance measures over three-year performance periods. Awards for which performance measures have not been met were excluded from the calculation of diluted earnings per share.
Recently issued accounting standards
Recently issued accounting standards
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 requires enhanced disclosures about significant segment expenses and enhanced disclosures in interim periods. The guidance in ASU 2023-07 is to be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023 and interim reporting periods in fiscal years beginning after December 31, 2024, with early adoption permitted. The Company adopted the guidance of ASU 2023-07 during the fourth quarter of 2025. See Operating Segments Note.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 is intended to improve income tax disclosure requirements by requiring specific disclosure in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The guidance in ASU 2023-09 will be effective for annual reporting periods in fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of ASU 2023-09 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2026 in its Annual Report on Form 10-K for the year ending October 31, 2026.
In November 2024, the FASB issued ASU 2024-03, Income Statement (Topic 220): Reporting Comprehensive Income. ASU 2024-03 does not change or remove current expense presentation requirements within the Consolidated Statements of Income. However, the amendments require disclosure, on an annual and interim basis, disaggregated information about certain income statement expense line items within the notes to the consolidated financial statements. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of ASU 2024-03 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2028.
v3.25.4
Inventories (Tables)
 3 Months Ended
Jan. 31, 2026
Inventory Disclosure [Abstract]  
Schedule of Inventories
Components of inventories were as follows:
 January 31, 2026October 31, 2025
Finished goods$243,587 $234,710 
Raw materials and component parts227,554 230,907 
Work-in-process61,504 57,306 
 532,645 522,923 
Obsolescence and other reserves(81,507)(78,109)
 $451,138 $444,814 
v3.25.4
Property, Plant and Equipment (Tables)
 3 Months Ended
Jan. 31, 2026
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
Components of property, plant and equipment were as follows:
January 31, 2026October 31, 2025
Land$32,761 $32,579 
Land improvements4,939 4,914 
Buildings363,125 360,038 
Machinery and equipment690,721 682,093 
Enterprise management system53,694 53,694 
Construction-in-progress40,298 29,522 
Leased property under finance leases28,656 27,680 
 1,214,194 1,190,520 
Accumulated depreciation(692,686)(673,606)
 $521,508 $516,914 
v3.25.4
Goodwill and other intangible assets (Tables)
 3 Months Ended
Jan. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Changes in Carrying Amount of Goodwill Changes in the carrying amount of goodwill for the three months ended January 31, 2026 by operating segment:
 IPSMFSATSTotal
Balance at October 31, 2025$1,210,366 $1,647,468 $446,851 $3,304,685 
Currency effect23,125 1,163 3,271 27,559 
Balance at January 31, 2026$1,233,491 $1,648,631 $450,122 $3,332,244 
Summary of Intangible Assets Subject to Amortization
Information regarding intangible assets subject to amortization:
 January 31, 2026
 Carrying 
Amount		Accumulated
Amortization		Net Book 
Value
Customer relationships$910,541 $405,243 $505,298 
Patent/technology costs237,558 162,588 74,970 
Trade name170,403 79,215 91,188 
Non-compete agreements8,686 8,686 — 
Other921 921 — 
Total$1,328,109 $656,653 $671,456 
 October 31, 2025
 Carrying 
Amount		Accumulated
Amortization		Net Book 
Value
Customer relationships$899,402 $390,751 $508,651 
Patent/technology costs235,255 155,865 79,390 
Trade name169,127 75,581 93,546 
Non-compete agreements8,596 8,596 — 
Other929 929 — 
Total$1,313,309 $631,722 $681,587 
v3.25.4
Pension and other postretirement plans (Tables)
 3 Months Ended
Jan. 31, 2026
Retirement Benefits [Abstract]  
Components of Net Periodic Benefits Cost
The components of net periodic pension costs for the three months ended January 31, 2026 and 2025 were:
 U.S.International
2026202520262025
Service cost$2,062 $2,531 $133 $232 
Interest cost4,580 4,691 604 623 
Expected return on plan assets(6,645)(6,609)(547)(638)
Amortization of prior service credit— — (2)(2)
Amortization of net actuarial (gain) loss1,051 474 (86)(67)
Total benefit cost$1,048 $1,087 $102 $148 
The components of other postretirement benefit costs, for plans in the United States, for the three months ended January 31, 2026 and 2025:
20262025
Service cost$35 $59 
Interest cost522 650 
Amortization of net actuarial gain(413)(126)
Total benefit cost$144 $583 
v3.25.4
Accumulated other comprehensive loss (Tables)
 3 Months Ended
Jan. 31, 2026
Equity [Abstract]  
Summary of Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive income (AOCI) consisted of:
Cumulative
translation and related hedging instruments		Pension and
postretirement 
benefit plan
adjustments		Accumulated
other 
comprehensive
income (loss)
Balance at October 31, 2025 (1)
$(50,518)$(49,939)$(100,457)
Other comprehensive income before reclassification adjustments36,775 (131)36,644 
Reclassifications from AOCI to Statement of Income (2)
— 550 550 
Tax impact6,184 (124)6,060 
Balance at January 31, 2026 (1)
$(7,559)$(49,644)$(57,203)
(1) Amounts net of tax.
(2) Included in the computation of net periodic cost (benefit) which is included in Other - net in our Consolidated Statements of Income. See Pension and other postretirement plans Note.
v3.25.4
Warranties (Tables)
 3 Months Ended
Jan. 31, 2026
Guarantees [Abstract]  
Reconciliation of Product Warranty Liability
Following is a reconciliation of the product warranty liability for the three months ended January 31, 2026 and 2025:
 20262025
Beginning balance at October 31$13,900 $13,538 
Accruals for warranties3,022 1,596 
Warranty payments(2,854)(2,856)
Currency adjustments233 (351)
Ending balance$14,301 $11,927 
v3.25.4
Operating segments (Tables)
 3 Months Ended
Jan. 31, 2026
Segment Reporting [Abstract]  
Reconciliation of Operating Profit (Loss) from Segments to Consolidated
The following table presents information about our reportable segments as further reconciled to consolidated GAAP financial results:
Three Months Ended
January 31, 2026January 31, 2025
Sales
Industrial Precision Solutions$326,861 $300,448 
Medical and Fluid Solutions193,183 193,609 
Advanced Technology Solutions149,417 121,363 
Total segment sales669,461 615,420 
Adjusted cost of sales
Industrial Precision Solutions(134,755)(113,147)
Medical and Fluid Solutions(96,555)(103,369)
Advanced Technology Solutions(72,029)(54,859)
Total segment adjusted cost of sales(303,339)(271,375)
Adjusted selling and administrative expenses
Industrial Precision Solutions(87,750)(80,169)
Medical and Fluid Solutions(34,261)(34,612)
Advanced Technology Solutions(46,375)(45,317)
Total segment adjusted selling and administrative expenses(168,386)(160,098)
Depreciation
Industrial Precision Solutions5,955 5,644 
Medical and Fluid Solutions7,840 8,704 
Advanced Technology Solutions1,587 1,584 
Total segment depreciation15,382 15,932 
EBITDA
Industrial Precision Solutions110,311 112,776 
Medical and Fluid Solutions70,206 64,332 
Advanced Technology Solutions32,600 22,771 
Total segment EBITDA213,117 199,879 
Inventory step-up amortization— (3,135)
Acquisition related costs— (1,030)
Severance and other— (5,961)
Depreciation and amortization(36,585)(37,030)
Corporate expenses(10,127)(11,776)
Interest expense(23,131)(26,559)
Interest and investment income390 941 
Other - net20,837 1,526 
Income before taxes$164,501 $116,855 
Schedule of Operating Segments, Long Lived Assets
The following table presents additional information about our reportable segments for the three months ended or period ended:
Industrial Precision SolutionsMedical and Fluid SolutionsAdvanced Technology SolutionsCorporateTotal
January 31, 2026
Amortization of intangibles$7,520 $9,671 $2,378 $— $19,569 
Identifiable assets (1)
1,881,578 2,187,997 747,941 1,143,406  5,960,922 
Property, plant and equipment expenditures3,265 5,325 8,717 206 17,513 
January 31, 2025
Amortization of intangibles$6,810 $9,437 $3,064 $— $19,311 
Identifiable assets (1)
1,737,555 2,240,225 734,046 1,159,700 5,871,526 
Property, plant and equipment expenditures5,070 9,330 2,124 4,875 21,399 
(1) Operating segment identifiable assets include notes and accounts receivable net of allowance for doubtful accounts, inventories net of reserves, property, plant and equipment net of accumulated depreciation and goodwill. Corporate assets are principally cash and cash equivalents, deferred income taxes, leases, headquarter facilities and intangible assets.
Sales and Long-lived Asset Information by Geographic Regions
We had significant net sales, measured based on their geographic destination, and long-lived assets in the following geographic areas:
January 31, 2026January 31, 2025
Net external sales for three months ended
Americas$261,930 $267,836 
Europe182,461 167,762 
Asia Pacific225,070 179,822 
Total net external sales$669,461 $615,420 
Long-lived assets
Americas$421,462 $465,600 
Europe108,566 103,813 
Asia Pacific61,238 56,849 
Total long-lived assets$591,266 $626,262 
v3.25.4
Fair value measurements (Tables)
 3 Months Ended
Jan. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis:
January 31, 2026TotalLevel 1Level 2Level 3
Net derivative contracts (1)
$(59,465)$— $(59,465)$— 
Deferred compensation plans (2)
(13,356)— (13,356)— 
Minority interest investment (3)
29,238 29,238 — — 
October 31, 2025TotalLevel 1Level 2Level 3
Net derivative contracts (1)
$(55,367)$— $(55,367)$— 
Deferred compensation plans (2)
(11,885)— (11,885)— 
(1) Derivative contracts are valued using an industry standard market approach, in which prices and other relevant information is generated by market transactions involving identical or comparable assets or liabilities. Refer to Derivative financial instruments note for balance sheet classification of derivatives.
(2) Executive officers and other highly compensated employees may defer up to 100% of their salary and annual cash incentive compensation and for executive officers, up to 90% of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.
(3) Refer to Investments note for additional details.
Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments.
 January 31, 2026October 31, 2025
 Carrying AmountFair ValueCarrying AmountFair Value
Long-term debt (including current portion)$1,984,051 $2,041,426 $1,996,254 $2,038,869 
v3.25.4
Derivative financial instruments (Tables)
 3 Months Ended
Jan. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location
The following table provides information regarding the balance sheet and income statement impacts of the Company's derivatives:
January 31, 2026Notional Amount $Prepaid and other current assetsOther assetsAccrued liabilitiesOther long-term liabilitiesType of hedge
Derivatives designated as hedges:
Cross-currency swap$928,098 $3,839 $— $10,041 $75,583 Net investment
Interest rate swap300,000 1,396 7,735 — — Fair value
Derivatives not designated as hedges:
Foreign currency forward contracts1,036,125 14,704 — 1,515 — 
Total$19,939 $7,735 $11,556 $75,583 
October 31, 2025Notional Amount $Prepaid and other current assetsOther assetsAccrued liabilitiesOther long-term liabilitiesType of hedge
Derivatives designated as hedges:
Cross-currency swap$863,904 $5,937 $73 $— $10,675 $676 $61,725 Net investment
Interest rate swap300,000 1,133 10,353 — — Fair value
Derivatives not designated as hedges:
Foreign currency forward contracts1,137,956 4,961 — 15,350 — 
Total$12,031 $10,353 $16,026 $61,725 
 Gain (Loss) Recognized Location
January 31, 2026January 31, 2025
Derivatives designated as hedges:
   Interest rate swaps$(2,355)$2,986  Interest expense
   Hedged item$2,355 $(2,986) Interest expense
   Cross-currency swap - interest component$3,628 $3,737  Interest expense
   Cross-currency swap - effective portion$(26,560)$37,038  Cumulative translation
Derivatives not designated as hedges
   Foreign currency forward contracts$23,579 $(4,363) Other-net
Foreign currency balance sheet remeasurement$(25,873)$4,694  Other-net
Schedule of Interest Rate Derivatives
The following table provides information regarding the Company's outstanding interest rate derivatives that were used to hedge changes in fair value attributable to interest rate risk:
Interest rate swaps - notional amountCumulative adjustment to long-term debt from application of hedge accountingCarrying value of hedged debt
Interest rate swaps$300,000 $9,131 $309,131 
v3.25.4
Long-term debt (Tables)
 3 Months Ended
Jan. 31, 2026
Debt Disclosure [Abstract]  
Long-Term Debt
A summary of long-term debt is as follows:
 January 31, 2026October 31, 2025
Notes Payable $4,312 $— 
Revolving credit agreement, due 2031400,000 — 
Revolving credit agreement, due 2028— 135,000 
Term loan due 2026— 265,000 
Senior notes, due 2026-202720,000 20,000 
Senior notes, due 2026-2030130,000 130,000 
5.600% Notes due 2028350,000 350,000 
5.800% Notes due 2033500,000 500,000 
4.500% Notes due 2029600,000 600,000 
 2,004,312 2,000,000 
Less current maturities54,312 315,000 
Less unamortized debt issuance costs13,978 13,167 
Less bond discounts1,971 2,065 
Plus impact of interest rate swaps9,131 11,486 
Long-term maturities$1,943,182 $1,681,254 
v3.25.4
Significant accounting policies - Additional Information (Detail) - shares
shares in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Significant Accounting Policies [Line Items]    
Less than 50% Ownership Percentage, Accounted for under the Equity Method of Investment 50.00%  
Corporate Performance Measurement Period 3 years  
Stock Options    
Significant Accounting Policies [Line Items]    
Options for common shares excluded from computation of diluted earning per share (in shares) 73 193
v3.25.4
Receivables (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Oct. 31, 2025
Credit Loss [Abstract]      
Accounts receivable, after allowance for credit loss $ 6,504   $ 7,408
Provisions for losses on receivables $ (589) $ (382)  
v3.25.4
Inventories - Schedule of Inventories (Detail) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Inventory Disclosure [Abstract]    
Finished goods $ 243,587 $ 234,710
Raw materials and component parts 227,554 230,907
Work-in-process 61,504 57,306
Inventories - gross 532,645 522,923
Obsolescence and other reserves (81,507) (78,109)
Inventories - net $ 451,138 $ 444,814
v3.25.4
Property, Plant and Equipment (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Oct. 31, 2025
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 1,214,194   $ 1,190,520
Accumulated depreciation (692,686)   (673,606)
Property, plant and equipment - net 521,508   516,914
Depreciation 17,016 $ 17,720  
Land      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 32,761   32,579
Land improvements      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 4,939   4,914
Buildings      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 363,125   360,038
Machinery and equipment      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 690,721   682,093
Enterprise management system      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 53,694   53,694
Construction-in-progress      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 40,298   29,522
Leased property under finance leases      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 28,656   $ 27,680
v3.25.4
Goodwill and other intangible assets - Summary of Changes in Carrying Amount of Goodwill (Detail)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 3,304,685
Currency effect 27,559
Ending balance 3,332,244
Industrial Precision Solutions [Member]  
Goodwill [Roll Forward]  
Beginning balance 1,210,366
Currency effect 23,125
Ending balance 1,233,491
Medical and Fluid Solutions  
Goodwill [Roll Forward]  
Beginning balance 446,851
Currency effect 3,271
Ending balance 450,122
Medical and Fluid Solutions  
Goodwill [Roll Forward]  
Beginning balance 1,647,468
Currency effect 1,163
Ending balance $ 1,648,631
v3.25.4
Goodwill and other intangible assets - Summary of Intangible Assets Subject to Amortization (Detail) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount $ 1,328,109 $ 1,313,309
Accumulated Amortization 656,653 631,722
Net Book  Value 671,456 681,587
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount 910,541 899,402
Accumulated Amortization 405,243 390,751
Net Book  Value 505,298 508,651
Patent/technology costs    
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount 237,558 235,255
Accumulated Amortization 162,588 155,865
Net Book  Value 74,970 79,390
Trade name    
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount 170,403 169,127
Accumulated Amortization 79,215 75,581
Net Book  Value 91,188 93,546
Non-compete agreements    
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount 8,686 8,596
Accumulated Amortization 8,686 8,596
Net Book  Value 0 0
Other    
Finite-Lived Intangible Assets [Line Items]    
Carrying  Amount 921 929
Accumulated Amortization 921 929
Net Book  Value $ 0 $ 0
v3.25.4
Goodwill and other intangible assets - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization of intangibles $ 19,569 $ 19,311
v3.25.4
Pension and other postretirement plans - Net Periodic Benefit Cost (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Pension Plans | UNITED STATES    
Defined Benefit Plan Disclosure [Line Items]    
Service cost $ 2,062 $ 2,531
Interest cost 4,580 4,691
Expected return on plan assets (6,645) (6,609)
Amortization of prior service credit 0 0
Amortization of net actuarial gain 1,051 474
Total benefit cost 1,048 1,087
Pension Plans | International    
Defined Benefit Plan Disclosure [Line Items]    
Service cost 133 232
Interest cost 604 623
Expected return on plan assets (547) (638)
Amortization of prior service credit (2) (2)
Amortization of net actuarial gain (86) (67)
Total benefit cost 102 148
Postretirement Benefit Costs | UNITED STATES    
Defined Benefit Plan Disclosure [Line Items]    
Service cost 35 59
Interest cost 522 650
Amortization of net actuarial gain (413) (126)
Total benefit cost $ 144 $ 583
v3.25.4
Income taxes (Detail)
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Income Tax Disclosure [Abstract]    
Effective tax rates 18.90% 19.00%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00%  
v3.25.4
Accumulated other comprehensive loss - Summary of Accumulated Other Comprehensive Loss (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance $ 3,043,571 $ 2,932,192
Reclassifications from AOCI to Statement of Income (2) 42,959 (51,679)
Ending balance 3,112,106 2,876,611
Accumulated Other Comprehensive Income (Loss)    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (100,457) (184,840)
Other comprehensive income before reclassification adjustments (36,644)  
Ending balance (57,203) $ (236,007)
Other Comprehensive Income (Loss), Reclassifications from AOCI to Statement of Income 550  
Other Comprehensive Income (Loss), Tax (6,060)  
Cumulative translation and related hedging instruments    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (50,518)  
Other comprehensive income before reclassification adjustments (36,775)  
Ending balance (7,559)  
Other Comprehensive Income (Loss), Tax (6,184)  
Pension and postretirement  benefit plan adjustments    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (49,939)  
Other comprehensive income before reclassification adjustments 131  
Ending balance (49,644)  
Other Comprehensive Income (Loss), Reclassifications from AOCI to Statement of Income 550  
Other Comprehensive Income (Loss), Tax $ (124)  
v3.25.4
Warranties - Additional Information (Detail)
 3 Months Ended
Jan. 31, 2026
Guarantees [Abstract]  
Product warranty period 1 year
v3.25.4
Warranties - Reconciliation of Product Warranty Liability (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]    
Beginning balance $ 13,900 $ 13,538
Accruals for warranties 3,022 1,596
Warranty payments (2,854) (2,856)
Currency adjustments 233 (351)
Ending balance $ 14,301 $ 11,927
v3.25.4
Operating segments - Additional Information (Detail)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
USD ($)
segment
Jan. 31, 2025
USD ($)
Segment Reporting [Abstract]    
Number of Reportable Segments | segment 3  
Number of operating segments | segment 3  
Segment Reporting Information [Line Items]    
Sales $ 669,461 $ 615,420
Long-Lived Assets 591,266 626,262
UNITED STATES    
Segment Reporting Information [Line Items]    
Sales 198,523 208,820
Long-Lived Assets $ 412,713 $ 450,029
v3.25.4
Operating segments - Reconciliation of Segment Operating Income to Consolidated Income Before Income Taxes (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Segment Reporting Information [Line Items]    
Sales $ 669,461 $ 615,420
Adjusted cost of sales (303,339) (271,375)
Adjusted selling and administrative expenses (168,386) (160,098)
Depreciation 15,382 15,932
EBITDA 213,117 199,879
Inventory step-up amortization 0 (3,135)
Acquisition related costs 0 (1,030)
Severance and other 0 (5,961)
Depreciation and amortization (36,585) (37,030)
Corporate expenses (10,127) (11,776)
Interest expense (23,131) (26,559)
Interest and investment income 390 941
Other - net 20,837 1,526
Income before taxes 164,501 116,855
Operating Segments | Industrial Precision Solutions    
Segment Reporting Information [Line Items]    
Sales 326,861 300,448
Adjusted cost of sales (134,755) (113,147)
Adjusted selling and administrative expenses (87,750) (80,169)
Depreciation 5,955 5,644
EBITDA 110,311 112,776
Operating Segments | Medical and Fluid Solutions    
Segment Reporting Information [Line Items]    
Sales 193,183 193,609
Adjusted cost of sales (96,555) (103,369)
Adjusted selling and administrative expenses (34,261) (34,612)
Depreciation 7,840 8,704
EBITDA 70,206 64,332
Operating Segments | Advanced Technology Solutions    
Segment Reporting Information [Line Items]    
Sales 149,417 121,363
Adjusted cost of sales (72,029) (54,859)
Adjusted selling and administrative expenses (46,375) (45,317)
Depreciation 1,587 1,584
EBITDA $ 32,600 $ 22,771
v3.25.4
Operating Segments - Reportable Segments (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Oct. 31, 2025
Segment Reporting Information [Line Items]      
Amortization of intangibles $ 19,569 $ 19,311  
Assets 5,960,922   $ 5,917,681
Total identifiable assets for reportable segments 5,960,922 5,871,526  
Property, plant and equipment expenditures 17,513 21,399  
Operating Segments | Industrial Precision Solutions      
Segment Reporting Information [Line Items]      
Amortization of intangibles 7,520 6,810  
Assets 1,881,578 1,737,555  
Property, plant and equipment expenditures 3,265 5,070  
Operating Segments | Medical and Fluid Solutions      
Segment Reporting Information [Line Items]      
Amortization of intangibles 9,671 9,437  
Assets 2,187,997 2,240,225  
Property, plant and equipment expenditures 5,325 9,330  
Operating Segments | Advanced Technology Solutions      
Segment Reporting Information [Line Items]      
Amortization of intangibles 2,378 3,064  
Assets 747,941 734,046  
Property, plant and equipment expenditures 8,717 2,124  
Corporate      
Segment Reporting Information [Line Items]      
Amortization of intangibles 0 0  
Assets 1,143,406 1,159,700  
Property, plant and equipment expenditures $ 206 $ 4,875  
v3.25.4
Operating segments - Sales Information by Geographic Regions and Long-Lived Assets (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Revenues from External Customers and Long-Lived Assets [Line Items]    
Sales $ 669,461 $ 615,420
Americas    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Sales 261,930 267,836
Europe    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Sales 182,461 167,762
Asia Pacific    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Sales $ 225,070 $ 179,822
v3.25.4
Operating segments - Long Lived Assets (Detail) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Segment Reporting Information [Line Items]    
Long-Lived Assets $ 591,266 $ 626,262
Americas    
Segment Reporting Information [Line Items]    
Long-Lived Assets 421,462 465,600
Europe    
Segment Reporting Information [Line Items]    
Long-Lived Assets 108,566 103,813
Asia Pacific    
Segment Reporting Information [Line Items]    
Long-Lived Assets $ 61,238 $ 56,849
v3.25.4
Investments, All Other Investments (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Oct. 31, 2025
Investments, All Other Investments [Abstract]    
Investments Subject to Measurement Alternative $ 7,335 $ 13,996
Alternative Investment 29,238  
Unrealized Gain (Loss) on Investments $ (22,238)  
v3.25.4
Fair value measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative, Fair Value, Net $ (59,465) $ (55,367)
Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Deferred compensation plans (13,356) (11,885)
Minority Interest Investment 29,238  
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative, Fair Value, Net (59,465) (55,367)
Level 2 | Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Deferred compensation plans (13,356) $ (11,885)
Level 1 | Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Minority Interest Investment 29,238  
Level 3 | Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Minority Interest Investment $ 0  
v3.25.4
Fair value measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Additional Information) (Detail)
 3 Months Ended
Jan. 31, 2026
Fair Value Disclosures [Abstract]  
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum 100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum 90.00%
v3.25.4
Fair value measurements - Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable (Detail) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Fair Value Disclosures [Abstract]    
Long-term debt, carrying amount $ 1,984,051 $ 1,996,254
Long-term debt, fair value $ 2,041,426 $ 2,038,869
v3.25.4
Derivative financial instruments - Additional Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Oct. 31, 2025
Sep. 09, 2024
Derivative [Line Items]      
Maturity of foreign currency forward contracts 90 days    
Due 2029      
Derivative [Line Items]      
Public Bond Offering   $ 600,000 $ 600,000
v3.25.4
Derivative financial instruments - Schedule of Fair Value Hedging Instruments (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Oct. 31, 2025
Derivative [Line Items]      
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) $ 9,131   $ 11,486
Prepaid Expenses and Other Current Assets [Member]      
Derivative [Line Items]      
Derivative Fair Value Of Derivative Asset, Both Designated and Not Designated as Hedges 19,939 $ 12,031  
Accrued Liabilities [Member]      
Derivative [Line Items]      
Derivative Fair Value Of Derivative Liability, Both Designated and Not Designated as Hedges 11,556 16,026  
Other Assets [Member]      
Derivative [Line Items]      
Derivative Fair Value Of Derivative Asset, Both Designated and Not Designated as Hedges 7,735 10,353  
Other Noncurrent Liabilities [Member]      
Derivative [Line Items]      
Derivative Fair Value Of Derivative Liability, Both Designated and Not Designated as Hedges 75,583 61,725  
Foreign Currency Forward Contracts | Cash Flow Hedging | Interest Expense      
Derivative [Line Items]      
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 2,355 (2,986)  
Foreign Currency Forward Contracts | Not Designated as Hedging Instrument      
Derivative [Line Items]      
Notional Amounts of foreign currency derivative contracts 1,036,125 1,137,956  
Gains (losses) on foreign currency forward contracts 23,579 (4,363)  
Change in unrealized gain (loss) on foreign currency derivative instruments (25,873) 4,694  
Foreign Currency Forward Contracts | Not Designated as Hedging Instrument | Prepaid Expenses and Other Current Assets [Member]      
Derivative [Line Items]      
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value 14,704 4,961  
Foreign Currency Forward Contracts | Not Designated as Hedging Instrument | Accrued Liabilities [Member]      
Derivative [Line Items]      
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value 1,515 15,350  
Foreign Currency Forward Contracts | Designated as Hedging Instrument | Cash Flow Hedging      
Derivative [Line Items]      
Notional Amounts of foreign currency derivative contracts 928,098 863,904  
Foreign Currency Forward Contracts | Designated as Hedging Instrument | Net Investment Hedging | Interest Expense      
Derivative [Line Items]      
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net 3,628 3,737  
Foreign Currency Forward Contracts | Designated as Hedging Instrument | Net Investment Hedging | Cumulative Translation      
Derivative [Line Items]      
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Effective Portion, Net (26,560) 37,038  
Foreign Currency Forward Contracts | Designated as Hedging Instrument | Prepaid Expenses and Other Current Assets [Member] | Cash Flow Hedging      
Derivative [Line Items]      
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value 3,839 5,937  
Foreign Currency Forward Contracts | Designated as Hedging Instrument | Accrued Liabilities [Member] | Cash Flow Hedging      
Derivative [Line Items]      
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value 10,041 676  
Foreign Currency Forward Contracts | Designated as Hedging Instrument | Other Assets [Member] | Cash Flow Hedging      
Derivative [Line Items]      
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value 0 0  
Foreign Currency Forward Contracts | Designated as Hedging Instrument | Other Noncurrent Liabilities [Member] | Cash Flow Hedging      
Derivative [Line Items]      
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value 75,583 61,725  
Interest Rate Swap | Cash Flow Hedging | Interest Expense      
Derivative [Line Items]      
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax (2,355) 2,986  
Interest Rate Swap | Designated as Hedging Instrument | Cash Flow Hedging      
Derivative [Line Items]      
Notional Amounts of foreign currency derivative contracts 300,000 300,000  
Interest Rate Swap | Designated as Hedging Instrument | Prepaid Expenses and Other Current Assets [Member] | Cash Flow Hedging      
Derivative [Line Items]      
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) 1,396 1,133  
Interest Rate Swap | Designated as Hedging Instrument | Other Assets [Member] | Cash Flow Hedging      
Derivative [Line Items]      
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) $ 7,735 $ 10,353  
v3.25.4
Derivative financial instruments - Schedule of Interest Rate Derivatives (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Jan. 31, 2025
Derivative [Line Items]      
Interest Rate Swap, Notional Amount $ 300,000    
Interest Rate Swap, Carrying Value 309,131    
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) 9,131 $ 11,486  
Prepaid Expenses and Other Current Assets [Member]      
Derivative [Line Items]      
Derivative Fair Value Of Derivative Asset, Both Designated and Not Designated as Hedges 19,939   $ 12,031
Other Assets [Member]      
Derivative [Line Items]      
Derivative Fair Value Of Derivative Asset, Both Designated and Not Designated as Hedges 7,735   10,353
Accrued Liabilities [Member]      
Derivative [Line Items]      
Derivative Fair Value Of Derivative Liability, Both Designated and Not Designated as Hedges 11,556   16,026
Other Noncurrent Liabilities [Member]      
Derivative [Line Items]      
Derivative Fair Value Of Derivative Liability, Both Designated and Not Designated as Hedges 75,583   61,725
Foreign Currency Forward Contracts | Not Designated as Hedging Instrument      
Derivative [Line Items]      
Notional Amounts of foreign currency derivative contracts 1,036,125   1,137,956
Foreign Currency Forward Contracts | Not Designated as Hedging Instrument | Prepaid Expenses and Other Current Assets [Member]      
Derivative [Line Items]      
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value 14,704   4,961
Foreign Currency Forward Contracts | Not Designated as Hedging Instrument | Accrued Liabilities [Member]      
Derivative [Line Items]      
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value 1,515   15,350
Foreign Currency Forward Contracts | Cash Flow Hedging | Designated as Hedging Instrument      
Derivative [Line Items]      
Notional Amounts of foreign currency derivative contracts 928,098   863,904
Foreign Currency Forward Contracts | Cash Flow Hedging | Designated as Hedging Instrument | Prepaid Expenses and Other Current Assets [Member]      
Derivative [Line Items]      
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value 3,839   5,937
Foreign Currency Forward Contracts | Cash Flow Hedging | Designated as Hedging Instrument | Other Assets [Member]      
Derivative [Line Items]      
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value 0   0
Foreign Currency Forward Contracts | Cash Flow Hedging | Designated as Hedging Instrument | Accrued Liabilities [Member]      
Derivative [Line Items]      
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value 10,041   676
Foreign Currency Forward Contracts | Cash Flow Hedging | Designated as Hedging Instrument | Other Noncurrent Liabilities [Member]      
Derivative [Line Items]      
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value 75,583   61,725
Interest Rate Swap | Cash Flow Hedging | Designated as Hedging Instrument      
Derivative [Line Items]      
Notional Amounts of foreign currency derivative contracts 300,000   300,000
Interest Rate Swap | Cash Flow Hedging | Designated as Hedging Instrument | Prepaid Expenses and Other Current Assets [Member]      
Derivative [Line Items]      
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) 1,396   1,133
Interest Rate Swap | Cash Flow Hedging | Designated as Hedging Instrument | Other Assets [Member]      
Derivative [Line Items]      
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) $ 7,735   $ 10,353
v3.25.4
Long-term debt - Long-Term Debt (Detail) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Sep. 09, 2024
Sep. 13, 2023
Jun. 06, 2023
Debt Instrument [Line Items]          
Short-Term Bank Loans and Notes Payable $ 4,312 $ 0      
Long-term debt 2,004,312 2,000,000      
Current maturities of long-term debt and notes payable 54,312 315,000      
Less unamortized debt issuance costs 13,978 13,167      
Debt Instrument, Unamortized Discount 1,971 2,065      
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) 9,131 11,486      
Long-term debt 1,943,182 1,681,254      
Senior notes, due 2026-2027          
Debt Instrument [Line Items]          
Senior notes 20,000 20,000      
Senior notes, due 2026-2030          
Debt Instrument [Line Items]          
Senior notes 130,000 130,000      
Due 2028          
Debt Instrument [Line Items]          
Public Bond Offering   350,000   $ 350,000  
Due 2033          
Debt Instrument [Line Items]          
Public Bond Offering   500,000   $ 500,000  
Due 2029          
Debt Instrument [Line Items]          
Public Bond Offering   600,000 $ 600,000    
Revolving Credit Agreement Due 2031          
Debt Instrument [Line Items]          
Revolving credit agreement, due 2028 400,000 0      
Revolving credit agreement, due 2028          
Debt Instrument [Line Items]          
Revolving credit agreement, due 2028 0 135,000      
Term Loan Due 2026          
Debt Instrument [Line Items]          
Term loan due 2026 $ 0 $ 265,000     $ 300,000
v3.25.4
Long-term debt - Additional Information (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 30, 2026
Oct. 31, 2025
Sep. 09, 2024
Sep. 13, 2023
Jun. 06, 2023
Revolving Credit Facility            
Debt Instrument [Line Items]            
Weighted average interest rate for borrowings 4.69%          
Senior notes, due 2026-2027            
Debt Instrument [Line Items]            
Weighted average interest rate for borrowings 3.19%          
Remaining weighted average life of notes 11 months 26 days          
Senior notes, due 2026-2030            
Debt Instrument [Line Items]            
Weighted average interest rate for borrowings 4.08%          
Remaining weighted average life of notes 2 years 4 months 20 days          
Due 2028            
Debt Instrument [Line Items]            
Weighted average interest rate for borrowings         5.60%  
Public Bond Offering     $ 350,000   $ 350,000  
Due 2033            
Debt Instrument [Line Items]            
Weighted average interest rate for borrowings         5.80%  
Public Bond Offering     500,000   $ 500,000  
Due 2029            
Debt Instrument [Line Items]            
Weighted average interest rate for borrowings       4.50%    
Public Bond Offering     600,000 $ 600,000    
Revolving Credit Agreement Due 2031            
Debt Instrument [Line Items]            
Revolving Facility Increased Maximum Borrowing Capacity   $ 1,200,000        
Revolving credit agreement, due 2028 $ 400,000   0      
Term Loan Due 2026            
Debt Instrument [Line Items]            
Term loan due 2026 0   265,000     $ 300,000
Revolving credit agreement, due 2028            
Debt Instrument [Line Items]            
Revolving Facility Increased Maximum Borrowing Capacity           $ 922,500
Revolving credit agreement, due 2028 $ 0   $ 135,000